January 26, 2023

Alverno Laboratories issued a comprehensive bulletin detailing updates and reminders for healthcare providers. It includes changes such as the referral of NT-proBNP testing to a reference lab effective immediately, the correct utilization of ARUP test codes DRGTU and DRNFB for drug screening, and reduced specimen requirements for blood bank antibody screens. Additionally, it highlights upcoming changes, such as the implementation of new reference ranges with the Soft 4.5 system upgrade and the transition of STI molecular testing to Abbott Alinity m instruments, allowing for the detection of up to three STIs in one sample. The bulletin provides detailed instructions and timelines for these changes, ensuring healthcare providers are informed and prepared for the transitions.